Literature DB >> 14595760

Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma.

Karine Poirier1, Céline Chalas, Frédérique Tissier, Philippe Couvert, Vincent Mallet, Alain Carrié, Agnès Marchio, Dario Sarli, Christine Gicquel, Stanislas Chaussade, Cherif Beljord, Jamel Chelly, Antoine Kerjean, Benoit Terris.   

Abstract

Significant production of the growth factor IGF2 has been reported in human hepatocellular carcinomas (HCCs). Disturbances associated with changes in methylation at this locus or affecting the 11p15.5 imprinting domain as a whole can be postulated in HCCs. In the present study, the methylation status of differentially methylated regions of the imprinted genes TSSC5, LIT1, and IGF2, which span the 11p15 domain, was analysed in 71 liver tissues from virus-associated and non-virus-associated HCCs compared with six normal liver tissues. Altered methylation of TSSC5 and LIT1 was observed in only 6% and 8% of HCCs, respectively, compared with 89% at the IGF2 locus, suggesting that these loci were not concomitantly dysregulated. These observations suggest that loss of parental-specific methylation at the IGF2 locus may be specifically associated with HCC, whether virus-associated or non-virus-associated, and arising in cirrhotic or non-cirrhotic livers. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595760     DOI: 10.1002/path.1477

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Oncogenic role of miR-483-3p at the IGF2/483 locus.

Authors:  Angelo Veronese; Laura Lupini; Jessica Consiglio; Rosa Visone; Manuela Ferracin; Francesca Fornari; Nicola Zanesi; Hansjuerg Alder; Gemma D'Elia; Laura Gramantieri; Luigi Bolondi; Giovanni Lanza; Patrizia Querzoli; Adriano Angioni; Carlo M Croce; Massimo Negrini
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

2.  Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.

Authors:  Emelyne Dejeux; Virginie Audard; Catherine Cavard; Ivo Glynne Gut; Benoit Terris; Jörg Tost
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

3.  Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma.

Authors:  Philippe Couvert; Alain Carrié; Jacques Pariès; Jenny Vaysse; Audrey Miroglio; Antoine Kerjean; Pierre Nahon; Jamel Chelly; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Ganne-Carrié
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Authors:  Mónica Enguita-Germán; Puri Fortes
Journal:  World J Hepatol       Date:  2014-10-27

5.  Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation.

Authors:  Ning Ma; Fuyuan Li; Dan Li; Yang Hui; Xidi Wang; Yu Qiao; Yanfen Zhang; Ying Xiang; Jianying Zhou; Lingyun Zhou; Xiaofei Zheng; Xu Gao
Journal:  Mol Cell Biochem       Date:  2011-11-04       Impact factor: 3.396

6.  Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.

Authors:  Supriya Sen; Magda Langiewicz; Hassan Jumaa; Nicholas J G Webster
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

7.  Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.

Authors:  H Y Yamada; G J Gorbsky
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

8.  Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma.

Authors:  Minoru Tomizawa; Hiromitsu Saisho
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 9.  Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Hend Mohamed El Tayebi; Ahmed Ihab Abdelaziz
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Till Krech; Britta Hasemeier; Elisa Schipper; Nora Schweitzer; Arndt Vogel; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.